Advances in medical therapy for pericardial diseases

References

• Imazio M. Contemporary management of pericardial diseases. Curr Opin Cardiol. 2012;27:308–317.
   PubMed Web of Science ®Google Scholar
• Kyto ̈ V, Sipila ̈ J, Rautava P. Clinical profile and influences on outcomes in patients hospitalized for acute pericarditis. Circulation. 2014;130:1601–1606.
   PubMed Web of Science ®Google Scholar
• Authors/Task Force Members, Adler Y, Charron P, Imazio M, et al. 2015 ESC guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015;36(42):2921-2964.
   Web of Science ®Google Scholar
• Imazio M, Gribaudo E, Gaita F. Recurrent pericarditis. Prog Cardiovasc Dis. 2017;59:360–368.
   PubMed Web of Science ®Google Scholar
• Imazio M, Gaita F. Diagnosis and treatment of pericarditis. Heart. 2015;101:1159–1168.
   PubMed Web of Science ®Google Scholar
• Vakamudi S, Ho N, Cremer PC. Pericardial effusions: causes, diagnosis, and management. Prog Cardiovasc Dis. 2017;59(4):380–388.
   PubMed Web of Science ®Google Scholar
• Lotan D, Wasserstrum Y, Fardman A. Usefulness of novel immunotherapeutic strategies for idiopathic recurrent pericarditis. Am J Cardiol. 2016;117:861–866.
   PubMed Web of Science ®Google Scholar
• Mayosi BM, Wiysonge CS, Ntsekhe M, et al. Mortality in patients treated for tuberculous pericarditis in sub-Saharan Africa. S Afr Med J. 2008;98:36–40.
   PubMed Web of Science ®Google Scholar
• LeWinter M. Acute pericarditis. New Engl J Med. 2014;371:2410–2416.
   PubMed Web of Science ®Google Scholar
• Slobodnick A, Shah B, Pillinger MH. Colchicine: old and new. Am J Med. 2015;128(5):461–470.
   PubMed Web of Science ®Google Scholar
• Rodríguez de la Serna A, Guindo SJ, Martí CV, et al. Colchicine for recurrent pericarditis. Lancet. 1987;2:1517.
   PubMed Web of Science ®Google Scholar
• Imazio M, Bobbio M, Cecchi E, et al. Colchicine in addition to conventional therapy for acute pericarditis. Circulation. 2005;112:2012–2016.
   PubMed Web of Science ®Google Scholar
• Imazio M, Bobbio M, Cecchi E, et al. Colchicine as first-choice therapy for recurrent pericarditis. Arch Intern Med. 2005;165(17):1987–1991.
   PubMed Web of Science ®Google Scholar
• Imazio M, Brucato A, Cemin R. Colchicine for recurrent pericarditis (CORP): a randomized trial. Ann Intern Med. 2011;155(7):409–414.
   PubMed Web of Science ®Google Scholar
• Imazio M, Brucato A, Cemin R. A randomized trial of colchicine for acute pericarditis. N Engl J Med. 2013;369:1522–1528.
   PubMed Web of Science ®Google Scholar
• Imazio M, Belli R, Brucato A, et al. Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial. Lancet. 2014;383:2232–2237.
   PubMed Web of Science ®Google Scholar
• Verma S, Eikelboom JW, Nidorf SM, et al. Colchicine in cardiac disease: a systematic review and meta-analysis of randomized controlled trials. BMC Cardiovasc Disord. 2015;15:96.
   PubMed Web of Science ®Google Scholar
• Alabed S, Pérez-Gaxiola G, Burls A. Colchicine for children with pericarditis: systematic review of clinical studies. Arch Dis Child. 2016;101(10):953–956.
   PubMed Web of Science ®Google Scholar
• Imazio M, Brucato A, Cumetti D, et al. Corticosteroids for recurrent pericarditis: high versus low doses: a nonrandomized observation. Circulation. 2008;118:667–671.
   PubMed Web of Science ®Google Scholar
• Alraies MC, AlJaroudi W, Yarmohammadi H, et al. Usefulness of cardiac magnetic resonance-guided management in patients with recurrent pericarditis. Am J Cardiol. 2015;115(4):542–547.
   PubMed Web of Science ®Google Scholar
• Alraies MC, Baibars M, Klein AL. When does pericarditis merit a workup for autoimmune or inflammatory disease? Cleve Clin J Med. 2015;82(5):285–286.
   PubMed Web of Science ®Google Scholar
• Vianello F, Cinetto F, Cavraro M, et al. Azathioprine in isolated recurrent pericarditis: a single centre experience. Int J Cardiol. 2011;147:477e478.
   Web of Science ®Google Scholar
• Imazio M, Lazaros G, Picardi E, et al. Intravenous human immunoglobulins for refractory recurrent pericarditis: a systematic review of all published cases. J Cardiovasc Med. 2016;17:263–269.
   Google Scholar
• Moretti M, Buiatti A, Merlo M, et al. Usefulness of high-dose intravenous human immunoglobulins treatment for refractory recurrent pericarditis. Am J Cardiol. 2013;112:1493–1498.
   PubMed Web of Science ®Google Scholar
• Rosa del Fresno M, Peralta J, Granados M, et al. Intravenous immunoglobulin therapy for refractory recurrent pericarditis. Pediatrics. 2014;134:1441–1446.
   Web of Science ®Google Scholar
• Finetti M, Insalaco A, Cantarini L, et al. Long-term efficacy of interleukin-1 receptor antagonist (anakinra) in corticosteroid-dependent and colchicine-resistant recurrent pericarditis. J Pediatr. 2014;164:1425e1431; e1421.
   PubMed Web of Science ®Google Scholar
• Lazaros G1, Vasileiou P1, Koutsianas C, et al. Anakinra for the management of resistant idiopathic recurrent pericarditis. Initial experience in 10 adult cases. Ann Rheum Dis. 2014 Dec;73(12):2215–2217.
   PubMed Web of Science ®Google Scholar
• Jain S, Thongprayoon C, Espinosa RE, et al. Effectiveness and safety of anakinra for management of refractory pericarditis. Am J Cardiol. 2015;116:1277e1279.
   Web of Science ®Google Scholar
• Brucato A, Imazio M, Gattorno M, et al. Effect of anakinra on recurrent pericarditis among patients with colchicine resistance and corticosteroid dependence: the AIRTRIP randomized clinical trial. JAMA. 2016;316(18):1906–1912.
   PubMed Web of Science ®Google Scholar
• Dalla Pozza R, Hartl D, Bechtold S, et al. Recurrent pericarditis in children: elevated cardiac autoantibodies. Clin Res Cardiol. 2007;96:168e175.
   Web of Science ®Google Scholar
• Imazio M, Cecchi E, Correndo L, et al. Treatment of refractory recurrent pericarditis. J Cardiovasc Med. 2007;8:748e753.
   Google Scholar
• Lessio S, Tona F, Rigoli A, et al. Cyclosporin A in the treatment of idiopathic recurrent pericarditis: a case report. J Clin Basic Cardiol. 1999;2:130e131.
   Google Scholar
• González Nieto JC, Monteagudo I, López-Longo FJ, et al. Idiopathic recurrent pericarditis treated successfully with tumour necrosis factor alpha blocking agents (anti-TNF-a). Clin Exp Rheumatol. 2013;31:776e778.
   Web of Science ®Google Scholar
• Mayosi BM, Ntsekhe M, Bosch J, et al. Prednisolone and mycobacterium indicus pranii in tuberculous pericarditis. N Engl J Med. 2014;371:1121–1130.
   PubMed Web of Science ®Google Scholar
• Khandaker MH, Schaff HV, Greason KL, et al. Pericardiectomy vs medical management in patients with relapsing pericarditis. Mayo Clin Proc. 2012;87:1062–1070.
   PubMed Web of Science ®Google Scholar
• Imazio M1, Trinchero R, Brucato A, et al. COlchicine for the Prevention of the Post-pericardiotomy Syndrome (COPPS): a multicentre, randomized, double-blind, placebo-controlled trial. Eur Heart J. 2010;31(22):2749–2754.
   PubMed Web of Science ®Google Scholar
• Imazio M, Brucato A, Ferrazzi P, et al. Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial. JAMA. 2014;312(10):1016–1023.
   PubMed Web of Science ®Google Scholar
• Meurin P, Lelay-Kubas S, Pierre B, et al. Colchicine for post-operative pericardial effusion: preliminary results of the POPE-2 study. J Am Coll Cardiol. 2015;66(10):1198–1199.
   PubMed Web of Science ®Google Scholar
• Izadi Amoli A, Bozorgi A, HajHossein Talasaz A, et al. Efficacy of colchicine versus placebo for the treatment of pericardial effusion after open-heart surgery: A randomized, placebo-controlled trial. Am Heart J. 2015;170(6):1195–1201.
   PubMed Web of Science ®Google Scholar
• Prete M, Urso L, Fatone MC, et al. Antiphospholipids syndrome complicated by a systemic capillary leak-like syndrome treated with steroids and intravenous immunoglobulins: A case report. Medicine (Baltimore). 2016;95(5):e2648.
   PubMed Web of Science ®Google Scholar
• Nicolazzi MA, Carnicelli A, Fuorlo M, et al. Cardiovascular involvement in Erdheim-Chester disease: a case report and review of the literature. Medicine (Baltimore). 2015;94(43):e1365.
   PubMed Web of Science ®Google Scholar
• Ferrero E, Belloni D, Corti A, et al. TNF-α in Erdheim-Chester disease pericardial effusion promotes endothelial leakage in vitro and is neutralized by infliximab. Rheumatology (Oxford). 2014;53(1):198–200.
   PubMed Web of Science ®Google Scholar
• Houston BA, Miller PE, Rooper LM, et al. CLINICAL PROBLEM-SOLVING. From dancing to debilitated. N Engl J Med. 2016;374(5):470–477.
   PubMedGoogle Scholar